Pharmacological evaluation of HM41322, a novel SGLT1/2 dual inhibitor, <i>in vitro</i> and <i>in vivo</i>.

Pharmacological evaluation of HM41322, a novel SGLT1/2 dual inhibitor, in vitro and in vivo.

Lee, Kyu Hang; Lee, Sang Don; Kim, Namdu; Suh, Kwee Hyun; Kim, Young Hoon; Sim, Sang Soo.

Afiliação

Lee KH; Hanmi Research Center, Hanmi Pharmaceutical Co., Ltd, Hwaseong 18469, Korea.
Lee SD; Hanmi Research Center, Hanmi Pharmaceutical Co., Ltd, Hwaseong 18469, Korea.
Kim N; Hanmi Research Center, Hanmi Pharmaceutical Co., Ltd, Hwaseong 18469, Korea.
Suh KH; Hanmi Research Center, Hanmi Pharmaceutical Co., Ltd, Hwaseong 18469, Korea.
Kim YH; Hanmi Research Center, Hanmi Pharmaceutical Co., Ltd, Hwaseong 18469, Korea.
Sim SS; College of Pharmacy, Chung-Ang University, Seoul 06974, Korea.

Korean J Physiol Pharmacol ; 23(1): 55-62, 2019 Jan.

Article em En | MEDLINE | ID: mdl-30627010